Chinese Society of Clinical Oncology (CSCO) Breast Cancer guidelines 2024.

ABSTRACT:

Background

Developing guidelines for the diagnosis and treatment of common cancers in China based on the evidence-based practice, the availability of diagnosis and treatment products, and the up-to-date advances in precision medicine is one of the basic tasks of the Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) Committee.

Methods

Protocols with high evidence level and good availability are used as the Level I recommendations; protocols with relatively high evidence level but slightly lower expert consensus or with poor availability are used as the Level II recommendations; and protocols that are clinically applicable but with low evidence level are regarded as the Level III recommendations. Based on the findings of clinical research at home and abroad and the

SUBMITTER: Li J 

PROVIDER: S-EPMC11341997 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature